1. Home
  2. TISI vs GALT Comparison

TISI vs GALT Comparison

Compare TISI & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TISI
  • GALT
  • Stock Information
  • Founded
  • TISI 1973
  • GALT 2000
  • Country
  • TISI United States
  • GALT United States
  • Employees
  • TISI N/A
  • GALT N/A
  • Industry
  • TISI Other Consumer Services
  • GALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TISI Consumer Discretionary
  • GALT Health Care
  • Exchange
  • TISI Nasdaq
  • GALT Nasdaq
  • Market Cap
  • TISI 77.8M
  • GALT 83.5M
  • IPO Year
  • TISI N/A
  • GALT N/A
  • Fundamental
  • Price
  • TISI $17.62
  • GALT $3.60
  • Analyst Decision
  • TISI
  • GALT Buy
  • Analyst Count
  • TISI 0
  • GALT 2
  • Target Price
  • TISI N/A
  • GALT $6.00
  • AVG Volume (30 Days)
  • TISI 5.2K
  • GALT 309.6K
  • Earning Date
  • TISI 08-07-2025
  • GALT 08-12-2025
  • Dividend Yield
  • TISI N/A
  • GALT N/A
  • EPS Growth
  • TISI N/A
  • GALT N/A
  • EPS
  • TISI N/A
  • GALT N/A
  • Revenue
  • TISI $851,327,000.00
  • GALT N/A
  • Revenue This Year
  • TISI N/A
  • GALT N/A
  • Revenue Next Year
  • TISI N/A
  • GALT N/A
  • P/E Ratio
  • TISI N/A
  • GALT N/A
  • Revenue Growth
  • TISI N/A
  • GALT N/A
  • 52 Week Low
  • TISI $8.81
  • GALT $0.73
  • 52 Week High
  • TISI $26.77
  • GALT $3.90
  • Technical
  • Relative Strength Index (RSI)
  • TISI 45.48
  • GALT 77.43
  • Support Level
  • TISI $16.66
  • GALT $2.54
  • Resistance Level
  • TISI $17.94
  • GALT $3.15
  • Average True Range (ATR)
  • TISI 0.70
  • GALT 0.27
  • MACD
  • TISI 0.06
  • GALT 0.05
  • Stochastic Oscillator
  • TISI 43.24
  • GALT 88.64

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: